Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 346-350, January 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de la Maza, L. M.
Right arrow Articles by Peterson, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de la Maza, L. M.
Right arrow Articles by Peterson, E. M.

Dependence of the in Vitro Antiproliferative Activity of Recombinant Human {gamma}-Interferon on the Concentration of Tryptophan in Culture Media

Luis M. de la Maza and Ellena M. Peterson

Department of Pathology, University of California Irvine, Irvine, California 92717

In addition to its antiviral and antibacterial activities, recombinant human {gamma}-interferon (rHuIFN-{gamma}) can exert an antiproliferative effect on human cell lines. The mechanisms involved in this antiproliferative activity are poorly understood, but it is known that IFN-{gamma} can induce indoleamine 2,3-dioxygenase, which enhances tryptophan metabolism and thus depletes the cellular pool of this amino acid. In the present study we have examined the effect of different tryptophan concentrations on the antiproliferative activity of rHuIFN-{gamma} on four human tumor cell lines, HeLa 229, HEp-2, A549, and T24. Cells were grown in the presence of rHuIFN-{gamma} (0.01 to 100 ng/ml) and/or tryptophan (10 to 400 µg/ml) for 7 days at which time they were counted. rHuIFN-{gamma} (4 ng/ml) inhibited the growth of A549 and T24 cells by 50%. Hep-2 and HeLa 229 cells were more sensitive to the rHuIFN-{gamma} induced antiproliferative effects, requiring only 0.4 ng/ml for a 50% inhibition. Addition of tryptophan to the media at concentrations from 10 to 100 µg/ml resulted in a significant blockage of the antiproliferative activity of rHuIFN-{gamma}. For example, when 50 µg/ml of tryptophan were added to the media, 10 times more rHuIFN-{gamma} (4 ng/ml) was needed to inhibit HeLa 229 cells by 50% of the control. The A549 was the most sensitive cell line to the modulatory activity of the tryptophan. Addition of 10 µg/ml of tryptophan changed the amount of rHuIFN-{gamma} needed to produce a 50% inhibition from 4 ng/ml to 100 ng/ml. In summary, in the four human tumor cell lines tested, the antiproliferative activity of rHuIFN-{gamma} could be modulated by the concentration of tryptophan in the media.

Received 7/31/87. Revised 10/15/87. Accepted 10/16/87.




This article has been cited by other articles:


Home page
BloodHome page
P. Terness, J.-J. Chuang, T. Bauer, L. Jiga, and G. Opelz
Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?
Blood, March 15, 2005; 105(6): 2480 - 2486.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Maneglier, C. Rogez-Kreuz, P. Cordonnier, P. Therond, C. Advenier, D. Dormont, P. Clayette, and O. Spreux-Varoquaux
Simultaneous Measurement of Kynurenine and Tryptophan in Human Plasma and Supernatants of Cultured Human Cells by HPLC with Coulometric Detection
Clin. Chem., November 1, 2004; 50(11): 2166 - 2168.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
U. Chatterji, J. E. Riby, T. Taniguchi, E. L. Bjeldanes, L. F. Bjeldanes, and G. L. Firestone
Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells
Carcinogenesis, July 1, 2004; 25(7): 1119 - 1128.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
P. Terness, T. M. Bauer, L. Rose, C. Dufter, A. Watzlik, H. Simon, and G. Opelz
Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase-expressing Dendritic Cells: Mediation of Suppression by Tryptophan Metabolites
J. Exp. Med., August 19, 2002; 196(4): 447 - 457.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. P. Ceravolo, A. C. L. Chaves, C. A. Bonjardim, D. Sibley, A. J. Romanha, and R. T. Gazzinelli
Replication of Toxoplasma gondii, but Not Trypanosoma cruzi, Is Regulated in Human Fibroblasts Activated with Gamma Interferon: Requirement of a Functional JAK/STAT Pathway
Infect. Immun., May 1, 1999; 67(5): 2233 - 2240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.